However, no significant differences were observed between the two groups in terms of age, sex, LVEF, number of prior cardiovascular diseases, drugs used (including statin, diuretic, beta-blocker, ACEI/ARB/ARNI, digoxin, hydralazine, nitrate, anticoagulant, aspirin, and P2Y12 inhibitor), CHA2DS2-VASc score, SAMe-TT2R2 score, history of Cardiac Implantable Electronic Devices (CIED), and other laboratory testing. The gene discussed is P2RY12; the disease is cardiovascular disorder.